Device deployment issue, Product dose omission issue
Drugs: SIMPONI
- Safetyreportversion
- 1
- Safetyreportid
- 26940079
- Primarysourcecountry
- AU
- Occurcountry
- AU
- Transmissiondateformat
- 102
- Transmissiondate
- 20260709
- Reporttype
- 1
- Serious
- 2
- Seriousnessdeath
- 2
- Seriousnesslifethreatening
- 2
- Seriousnesshospitalization
- 2
- Seriousnessdisabling
- 2
- Seriousnesscongenitalanomali
- 2
- Seriousnessother
- 2
- Receivedateformat
- 102
- Receivedate
- 20260630
- Receiptdateformat
- 102
- Receiptdate
- 20260630
- Fulfillexpeditecriteria
- 5
- Companynumb
- AU-JNJFOC-20260618680
- Primarysource
- Reportercountry
- AU
- Qualification
- 3
- Sender
- Sendertype
- 6
- Senderorganization
- JOHNSON AND JOHNSON
- Receiver
- Receivertype
- 6
- Receiverorganization
- FDA
- Patient
- Reaction
- Reactionmeddraversionpt
- 29.0
- Reactionmeddrapt
- Device deployment issue
- Reactionoutcome
- 6
- Reactionmeddraversionpt
- 29.0
- Reactionmeddrapt
- Product dose omission issue
- Reactionoutcome
- 6
- Drug
- Drugcharacterization
- 1
- Medicinalproduct
- SIMPONI
- Drugauthorizationnumb
- 125289
- Drugstructuredosagenumb
- 50
- Drugstructuredosageunit
- 003
- Drugseparatedosagenumb
- 1
- Drugdosagetext
- STRENGTH- 50.00 MG / 0.50 ML
- Drugdosageform
- Solution for injection in pre-filled pen
- Drugadministrationroute
- 058
- Drugindication
- Product used for unknown indication
- Actiondrug
- 5
- Drugrecurreadministration
- 3
- Drugadditional
- 3
- Activesubstance
- Activesubstancename
- GOLIMUMAB
